Inorganic nanosystems for therapeutic delivery: Status and prospects

Advanced Drug Delivery Reviews

Volumn 65, Issue 1, 2013, Pages 93-99

  Kim, Chang Soo ^a   Tonga, Gülen Yesilbag ^a   Solfiell, David ^a   Rotello, Vincent M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Drug delivery; Imaging agent; Inorganic nanomaterials; Multifunctional; Theragnostic; Upconversion

Indexed keywords

IMAGING AGENT; INORGANIC NANOMATERIALS; MULTIFUNCTIONAL; THERAGNOSTIC; UP-CONVERSION;

DRUG DELIVERY; MAGNETIC PROPERTIES; NANOSTRUCTURED MATERIALS; SUPERPARAMAGNETISM;

NANOSYSTEMS;

CISPLATIN; GOLD NANOPARTICLE; NANOMATERIAL; PACLITAXEL; QUANTUM DOT;

CANCER CELL; CANCER THERAPY; CELL CULTURE; CELL TRANSPORT; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; IMAGING SYSTEM; MAGNETISM; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTUM CHEMISTRY; QUANTUM YIELD; REVIEW;

DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE;

EID: 84873269060     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.08.011     Document Type: Review

References (46)

1. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9:615-627.
2. Jokerst J.V., Gambhir S.S. Molecular imaging with theranostic nanoparticles. Acc. Chem. Res. 2011, 44:1050-1060.
3. Kumar C.S., Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev. 2011, 63:789-808.
4. Doane T.L., Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 2012, 41:2885-2911.
5. Irrera A., Artoni P., Iacona F., Pecora E.F., Franzo G., Galli M., Fazio B., Boninelli S., Priolo F. Quantum confinement and electroluminescence in ultrathin silicon nanowires fabricated by a maskless etching technique. Nanotechnology 2012, 23:075204.
6. Smith A.M., Duan H., Mohs A.M., Nie S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev. 2008, 60:1226-1240.
7. Chatterjee D.K., Gnanasammandhan M.K., Zhang Y. Small upconverting fluorescent nanoparticles for biomedical applications. Small 2010, 6:2781-2795.
8. Liu Q., Yang T., Feng W., Li F. Blue-emissive upconversion nanoparticles for low-power-excited bioimaging in vivo. J. Am. Chem. Soc. 2012, 134:5390-5397.
9. Li Z., Zhang Y., Jiang S. Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv. Mater. 2008, 20:4765-4769.
10. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M.V., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
11. Walkey C.D., Chan W.C. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 2012, 41:2780-2799.
12. Albanese A., Chan W.C.W. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 2011, 5:5478-5489.
13. Cho E.C., Zhang Q., Xia Y.N. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat. Nanotechnol. 2011, 6:385-391.
14. Popovic Z., Liu W., Chauhan V.P., Lee J., Wong C., Greytak A.B., Insin N., Nocera D.G., Fukumura D., Jain R.K., Bawendi M.G. A nanoparticle size series for in vivo fluorescence imaging. Angew. Chem. Int. Ed Engl. 2010, 49:8649-8652.
15. Zhu Z.J., Ghosh P.S., Miranda O.R., Vachet R.W., Rotello V.M. Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. J. Am. Chem. Soc. 2008, 130:14139-14143.
16. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic sidechains. Bioconjug. Chem. 2004, 15:897-900.
17. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 2009, 21:2133-2148.
18. Leduc C., Jung J.M., Carney R.R., Stellacci F., Lounis B. Direct investigation of intracellular presence of gold nanoparticles via photothermal heterodyne imaging. ACS Nano 2011, 5:2587-2592.
19. Aili D., Gryko P., Sepulveda B., Dick J.A.G., Kirby N., Heenan R., Baltzer L., Liedberg B., Ryan M.P., Stevens M.M. Polypeptide folding-mediated tuning of the optical and structural properties of gold nanoparticle assemblies. Nano Lett. 2011, 11:5564-5573.
20. Sun C., Lee J.S., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 2008, 60:1252-1265.
21. Cho E.C., Glaus C., Chen J.Y., Welch M.J., Xia Y.N. Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol. Med. 2010, 16:561-573.
22. Sullivan D.C., Ferrari M. Nanotechnology and tumor imaging: seizing an opportunity. Mol. Imaging 2004, 3:364-369.
23. Gary-Bobo M., Hocine O., Brevet D., Maynadier M., Raehm L., Richeter S., Charasson V., Loock B., Morere A., Maillard P., Garcia M., Durand J.O. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int. J. Pharm. 2012, 423:509-515.
24. Mallidi S., Larson T., Tam J., Joshi P.P., Karpiouk A., Sokolov K., Emelianov S. Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett. 2009, 9:2825-2831.
25. Kumar R., Roy I., Ohulchanskky T.Y., Vathy L.A., Bergey E.J., Sajjad M., Prasad P.N. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4:699-708.
26. Anglin E.J., Cheng L., Freeman W.R., Sailor M.J. Porous silicon in drug delivery devices and materials. Adv. Drug Deliv. Rev. 2008, 60:1266-1277.
27. Bhattacharyya S., Kudgus R.A., Bhattacharya R., Mukherjee P. Inorganic nanoparticles in cancer therapy. Pharm. Res. 2011, 28:237-259.
28. Zhang X.Q., Xu X., Lam R., Giljohann D., Ho D., Mirkin C.A. Solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates. ACS Nano 2011, 5:6962-6970.
29. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. J. Am. Chem. Soc. 2007, 129:11653-11661.
30. Kim C.K., Ghosh P., Pagliuca C., Zhu Z.J., Menichetti S., Rotello V.M. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J. Am. Chem. Soc. 2009, 131:1360-1361.
31. Timko B.P., Dvir T., Kohane D.S. Remotely triggerable drug delivery systems. Adv. Mater. 2010, 22:4925-4943.
32. de la Rica R., Aili D., Stevens M.M. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev. 2012, 64:967-978.
33. Agasti S.S., Chompoosor A., You C.C., Ghosh P., Kim C.K., Rotello V.M. Photoregulated release of caged anticancer drugs from gold nanoparticles. J. Am. Chem. Soc. 2009, 131:5728-5729.
34. Park J.H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 2009, 8:331-336.
35. Park J.H., von Maltzahn G., Ong L.L., Centrone A., Hatton T.A., Ruoslahti E., Bhatia S.N., Sailor M.J. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv. Mater. 2010, 22:880-885.
36. Cheng Y., Samia A.C., Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc. 2008, 130:10643-10647.
37. Cheng K., Peng S., Xu C., Sun S. Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin. J. Am. Chem. Soc. 2009, 131:10637-10644.
38. Cheng Y., Meyers J.D., Agnes R.S., Doane T.L., Kenney M.E., Broome A.-M., Burda C., Basilion J.P. Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?. Small 2011, 7:2301-2306.
39. Huang X., Peng X., Wang Y., Wang Y., Shin D.M., El-Sayed M.A., Nie S. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010, 4:5887-5896.
40. Lee J.H., Lee K., Moon S.H., Lee Y., Park T.G., Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed Engl. 2009, 48:4174-4179.
41. Kim C., Agasti S.S., Zhu Z.J., Isaacs L., Rotello V.M. Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat. Chem. 2010, 2:962-966.
42. Xie J., Lee S., Chen X. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 2010, 62:1064-1079.
43. Dreaden E.C., Mackey M.A., Huang X.H., Kang B., El-Sayed M.A. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev. 2011, 40:3391-3404.
44. Yoo D., Lee J.H., Shin T.H., Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res. 2011, 44:863-874.
45. Thomas C.R., Ferris D.P., Lee J.H., Choi E., Cho M.H., Kim E.S., Stoddart J.F., Shin J.S., Cheon J., Zink J.I. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 2010, 132:10623-10625.
46. Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D., Moskovits M., Zhao D., Stucky G.D. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett. 2012, 12:61-67.